NCT04564586

Brief Summary

DPPFit is a Healthy Lifestyle Intervention designed to reformat the effective strategies of the Diabetes Prevention Program (NDPP) into a tool for use in a primary care setting. DPPFit is a 16-week technology-based intervention for diabetes prevention. In keeping with the National DPP educational sessions, the intervention weeks follow the order and presentation of the N-DPP 16 session topics. The goal is to develop a pragmatic translation of the DPP that is effective in the real-world setting of primary care clinic. The hope is that in doing so, those at risk of developing type II diabetes mellitus will have evidenced-based prevention methods at their disposal.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 27, 2020

Completed
29 days until next milestone

First Posted

Study publicly available on registry

September 25, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

2.7 years

First QC Date

August 27, 2020

Last Update Submit

August 31, 2021

Conditions

Keywords

mHealthreal-world settingprimary care interventiondiabetes preventionremotetranslation

Outcome Measures

Primary Outcomes (3)

  • Weight Loss

    Weight Loss by % of change and total weight change (kg)

    12 Months

  • Physical Activity

    Physical activity days/week, change \> 10% of PA, Kcal/week

    6 months

  • Inactivity

    Change in Sedentary Time, Mins/day

    6 months

Secondary Outcomes (2)

  • Health Related Quality of Life

    6 months

  • Hemoglobin A1c

    12 months

Study Arms (1)

Enhanced Intervention Group (EIG)

OTHER

The Enhanced Intervention Group was a subgroup of the participants that were invited for voluntary weekly meet-n-greet sessions in the Primary Care Clinic. These sessions were information and not educational sessions for the intervention. The entire EIG concept was to test a social component of participants by providing an informal opportunity for a DPPFit social group. The group sessions were terminated after only 5 weeks as a result of the Covid-19 pandemic. They were the only component of the DPPFit study that were face-to-face.

Behavioral: DPPFit

Interventions

DPPFitBEHAVIORAL

Participants issued Fitbit Device and set up Fitbit App. They are then enrolled in the automated text messaging platform. Day 1 of the intervention begins the Monday after consent. All consented participants receive the full intervention.

Enhanced Intervention Group (EIG)

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Non-institutionalized adult patients
  • Ages 18 - 55 years
  • Diagnosed as prediabetes or with HbA1c% values between 5.7-6.4%.

You may not qualify if:

  • Prior bariatric surgery
  • Participation in weight loss program or current weight loss medication.
  • History of T1DM or T2DM diagnosis
  • Use of medications to treat glucose intolerance, including biguanides and sulfonylureas.
  • History of infarction, angina, coronary artery bypass graft surgery, coronary angioplasty, congestive heart failure, or any condition that significantly limits their exercise such as peripheral arterial disease.
  • BMI (kg/m²)\< 18.5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Augusta University - General Internal Medicine Clinic

Augusta, Georgia, 30912, United States

Location

Related Publications (1)

  • Coughlin SS, Stewart J. Use of Consumer Wearable Devices to Promote Physical Activity: A Review of Health Intervention Studies. J Environ Health Sci. 2016 Nov;2(6):10.15436/2378-6841.16.1123. doi: 10.15436/2378-6841.16.1123. Epub 2016 Nov 30.

    PMID: 28428979BACKGROUND

MeSH Terms

Conditions

Prediabetic StateMetabolic Syndrome

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesInsulin ResistanceHyperinsulinism

Study Officials

  • Jessica L Stewart, MPH

    Augusta University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

August 27, 2020

First Posted

September 25, 2020

Study Start

January 1, 2020

Primary Completion

September 1, 2022

Study Completion

October 1, 2022

Last Updated

September 1, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations